Sciclone Pharma (SCLN) Tops Q2 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Sciclone Pharma (SCLN) Tops Q2 EPS by 14c

SciClone Reports Second Quarter 2015 Financial Results

August 10, 2015 4:01 PM EDT

FOSTER CITY, Calif., Aug. 10, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2015.

 

Revenues: In the second quarter 2015, SciClone reported revenues of $37.9 million, compared to $32.5 million for the same period in 2014. GAAP Diluted EPS: In the second quarter 2015, SciClone reported a GAAP diluted loss per share of $0.08, compared to earnings per share of $0.18 for the same period in 2014. Non-GAAP Diluted EPS: In the second... More